Roche Seeks EU Marketing Approval For Novel Eye Disease Drug Faricimab
Chugai Has Submitted The Japanese Filing
If approved, Roche’s bispecific antibody could become the first in a new class of medicines in years for treating macular degeneration and diabetic macular edema.
